Aeterna Zentaris Stock

Aeterna Zentaris Employees 2024

Aeterna Zentaris Employees

11

Ticker

AEZS.TO

ISIN

CA0079754028

WKN

A1439Z

In 2024, Aeterna Zentaris employed 11 people, a 0% change from the 11 number of employees in the previous year.

Aeterna Zentaris Aktienanalyse

What does Aeterna Zentaris do?

Aeterna Zentaris Inc. is a Canadian company that has been operating in the pharmaceutical industry since 1991. The company is headquartered in Quebec City, Canada and focuses on the development and commercialization of drugs for the treatment of cancer and hormonal disorders. The company started as a small biotech company called "Aeterna Laboratories" that focused on the research of growth hormones and hormonal disorders. In the late 90s, it merged with a German company called "Zentaris GmbH" that specialized in medical diagnostics and chemicals, creating Aeterna Zentaris AG, which was later renamed Aeterna Zentaris Inc. The company has acquired several companies and expanded its portfolio of drugs and treatment options. Aeterna Zentaris is a biopharmaceutical company engaged in preclinical and clinical development of therapeutics. The company's main strategy is to develop and promote innovative and differentiating drug candidates. It works closely with leading academic institutions, researchers, and other companies to advance the development of its products. Aeterna Zentaris has a diversified portfolio of drug candidates in various stages of clinical development. It has two main divisions: cancer treatment and hormonal disorders. The company focuses on developing cancer therapeutics for various types of cancers and also on the treatment of hormonal disorders, including diabetes, growth problems, hormonally related cancers, and menopause. Some of the company's important products include Macrilen, which is used for diagnosing growth hormone deficiency, Zoptrex, which is intended for the treatment of endometrial cancer, and Perifosine, a drug candidate for advanced colorectal cancer. Aeterna Zentaris has established itself as a leading biotech company in the field of cancer and hormone therapy. It has a diverse portfolio of drug candidates in different stages of clinical development. The company collaborates with researchers, medical institutions, and other companies to develop innovative and differentiating drug candidates. Aeterna Zentaris ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Aeterna Zentaris's Employee Base

Aeterna Zentaris's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Aeterna Zentaris's operational capacity and future potential.

Year-to-Year Comparison

Assessing Aeterna Zentaris's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Aeterna Zentaris's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Aeterna Zentaris’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Aeterna Zentaris stock

How many employees does Aeterna Zentaris have this year?

Aeterna Zentaris has 11 undefined employees this year.

How many employees did Aeterna Zentaris have compared to the previous year?

Compared to the previous year, Aeterna Zentaris had 0% more employees.

What impact did the number of employees have on the company Aeterna Zentaris?

The number of employees has a direct impact on the efficiency and productivity of Aeterna Zentaris. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Aeterna Zentaris?

The number of employees can also have an impact on investors of Aeterna Zentaris, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Aeterna Zentaris affect the company?

An increase in equity of Aeterna Zentaris can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Aeterna Zentaris's equity affect the company?

A reduction in equity of Aeterna Zentaris can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Aeterna Zentaris?

Some factors that can influence the equity of Aeterna Zentaris include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Aeterna Zentaris so important for investors?

The equity of Aeterna Zentaris is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Aeterna Zentaris influence the company?

The number of employees at Aeterna Zentaris can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Aeterna Zentaris evolved in recent years?

In recent years, the number of employees at Aeterna Zentaris has changed by 0.

How many employees does Aeterna Zentaris currently have?

Aeterna Zentaris currently has 11 undefined employees.

Why is the number of employees important for investors of Aeterna Zentaris?

The number of employees is important for investors of Aeterna Zentaris as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Aeterna Zentaris take to change the number of employees?

To change the number of employees, Aeterna Zentaris can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Aeterna Zentaris pay?

Over the past 12 months, Aeterna Zentaris paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aeterna Zentaris is expected to pay a dividend of 0 USD.

What is the dividend yield of Aeterna Zentaris?

The current dividend yield of Aeterna Zentaris is .

When does Aeterna Zentaris pay dividends?

Aeterna Zentaris pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aeterna Zentaris?

Aeterna Zentaris paid dividends every year for the past 0 years.

What is the dividend of Aeterna Zentaris?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aeterna Zentaris located?

Aeterna Zentaris is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aeterna Zentaris kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aeterna Zentaris from 11/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did Aeterna Zentaris pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Aeterna Zentaris in the year 2023?

In the year 2023, Aeterna Zentaris distributed 0 USD as dividends.

In which currency does Aeterna Zentaris pay out the dividend?

The dividends of Aeterna Zentaris are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Aeterna Zentaris stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Aeterna Zentaris

Our stock analysis for Aeterna Zentaris Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aeterna Zentaris Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.